Drugs / BMS-986454
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07171983 | Feb 2026 → Jun 2027 expected | rheumatoid arthritis | Bristol-Myers Squibb | Recruiting | No outcome recorded |
| Phase 1 | NCT06086886 | Nov 2023 → Dec 2024 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986454 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07171983 ↗ |